Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Splicing factor SF3B1 promotes endometrial carcinoma progression?

Does your brain favour high-calorie foods by default?

Parexel Clinical Research Associate Job For Biological Sciences

Splicing factor SF3B1 promotes endometrial carcinoma progression?
  • BiotechToday
  • World

Splicing factor SF3B1 promotes endometrial carcinoma progression?

bioxone October 12, 2020October 11, 2020

Arjama Roy, Amity University Kolkata

Endometrial cancer is the foremost common type of cancer that affects the feminine reproductive tract. It grows rapidly and tends to spread to other parts of the body. Earlier, the causative agent of endometrial carcinoma wasn’t known aside from the transcriptional effects of steroid hormones. As a result of which limited therapeutic options were provided to the diagnosed women. Recent work reveals that dysregulation of splicing factors can cause the generation of abnormal mature transcripts which drive tumorigenesis.

The study published within the Nature journal researchers stated that splicing factor- SF3B1, plays a vital role in carcinoma pathological progression. SF3B1 is one amongst the frequently mutated splicing factors in endometrium cancer. it’s a core component of the U2 nuclear ribonucleoprotein, which distinguishes the 3′ splice site at intron-exon junctions. SF3B1 appears to act as an oncogene in endometrial carcinoma as most of the mutation occurs in the hotspot. employing a tissue microarray, it’s found that endometrial tumours express more SF3B1 protein than non-cancerous tissues. Furthermore, SF3B1 is required for carcinoma cell proliferation, cell cycle progression. it’s also required for tumour cell migration and invasion. Furthermore, SF3B1 inhibitor Pladienolide-B reduces endometrial carcinoma cell proliferation, migration, and invasion in vitro. It also inhibits tumour growth in vivo. 

Alternative splicing events analysis revealed that SF3B1 depletion led to an alteration in many different splicing events. The analysis showed that KSR2 can likely candidate for SF3B1 facilitated functions in carcinoma. Researchers discovered that releasing of the KSR2 expression with SF3B1 knockdown partially restored the cell growth of carcinoma cells.

Also read: Does your brain favour high-calorie foods by default?

Source: Popli, P., Richters, M.M., Chadchan, S.B. et al. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation. Cell Death Dis 11, 842 (2020). https://doi.org/10.1038/s41419-020-03055-y. D.O.I-http://10.1038/s41419-020-03055-y.

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged alternative splicing alternative splicing of mRNA endometrial cancer endometrial cancer diagnosis endometrial cancer symptoms inhibitor splicing factor-SF3B1

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Parexel Clinical Research Associate Job For Biological Sciences

bioxone October 12, 2020

-Shristi Sharma, Team bioXone Parexel Clinical Research Associate Job For Biological Sciences. Life Science, Biological Sciences Clinical Research Associate II Jobs. Parexel Clinical Research Associate II Biological Science career. Parexel has job openings for biological sciences candidates. Check out all of the details on the same below: Parexel Vacancy Details Designation: Clinical Research Associate II […]

Related Post

  • BiotechToday
  • World

Are Care Home Residents more vulnerable to SARS-CoV-2?

bioxone March 8, 2021March 8, 2021

-Devyani Goswami, Amity University Kolkata One of the parts of the society which remains under huge threat for the spreading of the deadly SARS-CoV-2 is the care homes. Older people with health issues remain to be the vulnerable target of this virus. The shared living accommodations along with residents, staff and visitors in an enclosed […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Monitoring Brainwaves: Early Drug Non-Response detection can revolutionize the treatment of Depression

bioxone September 17, 2020September 17, 2020

–Sampriti Roy, Asutosh College The 21st-century treatment of depression involving psychotherapy and eclectic approaches has undoubtedly come a long way from earlier methods (like lobotomies). However, the standard treatment of MDD (Major Depression Disorder) today with antidepressants- normally SSRIs (Selective Serotonin Reuptake Inhibitors) can take around 4 weeks to months to show response-a duration that’s […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Inclusion in HIV Vaccine Trials: A Critical Need

BioTech Today July 19, 2021July 18, 2021

Agrima Bhatt, Rajasthan University HIV has been present in our society for more than 30 years, from Central Africa to the USA and around the world. Viruses, as we can observe from 2021, are hard to combat! From the 1700s till today, have we progressed in society to include everyone without prejudice. From this crucial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy